A Case and Proposed Mechanism of Catatonia During the Post-Acute Phase of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

David R. Spiegel, MD^a; Abbey McLean, MD^a; Alice Kisteneff, MD^a; Whitney Fidelis, BA^a; Jenna Frawley, BS^a; Daniel Connelly, BS^a; Aaron Lopacinski, BS^a; Nicole Crofton, BS^a; Callie Dacyczyn, BS^a; Ann Ayzman, BS^a; Bradley Conlin, BS^a; Andrew Rickelmann, BS^a; Merete Lund, BS^a; Vanessa Rave, MS^a

Prim Care Companion CNS Disord 2022;24(3):21cr03233

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (25)

Gouse BM, Spears WE, Nieves Archibald A, et al. Catatonia in a hospitalized patient with COVID-19 and proposed immune-mediated mechanism. Brain Behav Immun. 2020;89:529–530. PubMed CrossRef
Scheiner NS, Smith AK, Wohlleber M, et al. COVID-19 and catatonia: a case series and systematic review of existing literature. J Acad Consult Liaison Psychiatry. 2021;62(6):645–656. PubMed CrossRef
Varatharaj A, Thomas N, Ellul MA, et al; CoroNerve Study Group. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. (Published correction appears in Lancet Psychiatry. July 14, 2020.) Lancet Psychiatry. 2020;7(10):875–882. PubMed CrossRef
Bush G, Fink M, Petrides G, et al. Catatonia, I: rating scale and standardized examination. Acta Psychiatr Scand. 1996;93(2):129–136. PubMed CrossRef
Caan MP, Lim CT, Howard M. A case of catatonia in a man with COVID-19. Psychosomatics. 2020;61(5):556–560. PubMed CrossRef
Deocleciano de Araujo C, Schlittler LXC, Sguario RM, et al. Life-threatening catatonia associated with coronavirus disease 2019. J Acad Consult Liaison Psychiatry. 2021;62(2):256–257. PubMed CrossRef
Vazquez-Guevara D, Badial-Ochoa S, Caceres-Rajo KM, et al. Catatonic syndrome as the presentation of encephalitis in association with COVID-19. BMJ Case Rep. 2021;14(6):e240550. PubMed CrossRef
Fiaschè F, Adriani B, Mancinelli I, et al. Treatment of catatonia with asenapine in a patient with schizotypal personality disorder, psychotic depression and septic shock from SARS-CoV-2: a case report. CNS Neurol Disord Drug Targets. 2021;20(5):473–477. PubMed CrossRef
Zain SM, Muthukanagaraj P, Rahman N. Excited catatonia: a delayed neuropsychiatric complication of COVID-19 infection. Cureus. 2021;13(3):e13891. PubMed CrossRef
Torrico T, Kiong T, D’Assumpcao C, et al. Postinfectious COVID-19 catatonia: a report of two cases. Front Psychiatry. 2021;12:696347. PubMed CrossRef
Mulder J, Feresiadou A, Fällmar D, et al. Autoimmune encephalitis presenting with malignant catatonia in a 40-year-old male patient with COVID-19. Am J Psychiatry. 2021;178(6):485–489. PubMed CrossRef
Zandifar A, Badrfam R. Exacerbation of psychosis accompanied by seizure and catatonia in a patient with COVID-19: a case report. Psychiatry Clin Neurosci. 2021;75(2):63–64. PubMed CrossRef
Amouri J, Andrews PS, Heckers S, et al. A case of concurrent delirium and catatonia in a woman with coronavirus disease 2019. J Acad Consult Liaison Psychiatry. 2021;62(1):109–114. PubMed CrossRef
Austgen G, Meyers MS, Gordon M, et al. The use of electroconvulsive therapy in neuropsychiatric complications of coronavirus disease 2019: a systematic literature review and case report. J Acad Consult Liaison Psychiatry. 2022;63(1):86–93. PubMed CrossRef
Kwon HJ, Patel KH, Ramirez M, et al. A case of fatal catatonia in a COVID-19 patient. Cureus. 2021;13(7):e16529. PubMed CrossRef
Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18–22. PubMed CrossRef
Nalleballe K, Reddy Onteddu S, Sharma R, et al. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun. 2020;88:71–74. PubMed CrossRef
Nezgovorova V, Ferretti CJ, Pallanti S, et al. Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder. J Psychiatr Res. 2022;149:367–373. PubMed CrossRef
Fusunyan M, Praschan N, Fricchione G, et al. Akinetic mutism and coronavirus disease 2019: a narrative review. J Acad Consult Liaison Psychiatry. 2021;62(6):625–633. PubMed CrossRef
Zhou Z, Kang H, Li S, et al. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179–2184. PubMed CrossRef
Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiatry. 2021;78(6):682–683. PubMed CrossRef
Gubernatorova EO, Gorshkova EA, Polinova AI, et al. IL-6: relevance for immunopathology of SARS-CoV-2. Cytokine Growth Factor Rev. 2020;53:13–24. PubMed CrossRef
Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168–175. PubMed CrossRef
Rustad JK, Landsman HS, Ivkovic A, et al. Catatonia: an approach to diagnosis and treatment. Prim Care Companion CNS Disord. 2018;20(1):17f02202. PubMed CrossRef
Bartolommei N, Lattanzi L, Callari A, et al. Catatonia: a critical review and therapeutic recommendations. J Psychopathology. 2012;18:234–246.